Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.99.7 (
sialyltransferase
)
1,534
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A cytokine preparation from rat peritoneal exudate cells was studied. The preparation was pronase sensitive and heat labile, but was insensitive to trypsin treatment. Administration to rats resulted in elevated serum levels of alpha 1-acid glycoprotein,
sialyltransferase
activities and cortisol, but depressed serum albumin levels; in addition, hepatic
sialyltransferase
activities were increased and hepatic beta-galactosidase and
beta-N-acetylhexosaminidase
activities were depressed.
...
PMID:Studies on rat cytokines as mediators of the acute phase response. 634 Jun 81
In order to study structure-function relationships of lysosomal enzymes, human liver
beta-N-acetylhexosaminidase
(2-acetamido-2-deoxy-beta-D-hexoside acetamidodeoxyhexohydrolase, EC 3.2.1.52) has been purified by an extraction/affinity chromatography/ion-exchange procedure. The isoenzymes A and B, native as well as neuraminidase-treated, were incubated with a partially purified preparation of bovine colostrum
sialyltransferase
(CMP-N-acetylneuraminate: D-galactosyl-glycoprotein N-acetylneuraminyltransferase, EC 2.4.99.1). Native beta-N-acetylhexosaminidases were found to be poor acceptors for the
sialyltransferase
used. However, incorporation of sialic acid into neuraminidase-treated
beta-N-acetylhexosaminidase
A and B amounted to a 58 to 72% saturation of the theoretical acceptor sites, respectively. The acceptor specificity of the
sialyltransferase
suggests that Gal beta(1 leads to 4)-GlcNAc units may be present on at least part of the
beta-N-acetylhexosaminidase
A and B molecules. However, oligomannosidic-type chains may also occur on the lysosomal enzyme, as shown by sugar composition of the enzyme. The presence and/or amount of sialic acid residues does not appear to affect the kinetic properties of
beta-N-acetylhexosaminidase
A and B towards 4-methylumbelliferyl glycoside substrate.
...
PMID:Sialylation in vitro of purified human liver beta-D-N-acetylhexosaminidase. 645 69